| In-stent restenosis in the drug-eluting stent era GD Dangas, BE Claessen, A Caixeta, EA Sanidas, GS Mintz, R Mehran Journal of the American College of Cardiology 56 (23), 1897-1907, 2010 | 983 | 2010 |
| Impact of bleeding on mortality after percutaneous coronary intervention: results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking … R Mehran, S Pocock, E Nikolsky, GD Dangas, T Clayton, BE Claessen, ... JACC: Cardiovascular Interventions 4 (6), 654-664, 2011 | 448 | 2011 |
| ST-segment elevation myocardial infarction B Vogel, BE Claessen, SV Arnold, D Chan, DJ Cohen, E Giannitsis, ... Nature reviews Disease primers 5 (1), 39, 2019 | 443 | 2019 |
| Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial JPS Henriques, LP Hoebers, T Råmunddal, P Laanmets, E Eriksen, ... Journal of the American College of Cardiology 68 (15), 1622-1632, 2016 | 423 | 2016 |
| Long-term outcome of percutaneous coronary intervention for chronic total occlusions R Mehran, BE Claessen, C Godino, GD Dangas, K Obunai, S Kanwal, ... JACC: Cardiovascular Interventions 4 (9), 952-961, 2011 | 336 | 2011 |
| Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with … R Kornowski, R Mehran, G Dangas, E Nikolsky, A Assali, BE Claessen, ... Journal of the American College of Cardiology 58 (7), 704-711, 2011 | 332 | 2011 |
| Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention BEPM Claessen, RJ van der Schaaf, NJ Verouden, NK Stegenga, ... JACC: Cardiovascular Interventions 2 (11), 1128-1134, 2009 | 288 | 2009 |
| Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI … BE Claessen, GD Dangas, G Weisz, B Witzenbichler, G Guagliumi, ... European heart journal 33 (6), 768-775, 2012 | 279 | 2012 |
| Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice … EP Navarese, K Tandjung, B Claessen, F Andreotti, M Kowalewski, ... Bmj 347, 2013 | 259 | 2013 |
| Stent thrombosis: a clinical perspective BE Claessen, JPS Henriques, FA Jaffer, R Mehran, JJ Piek, GD Dangas JACC: Cardiovascular interventions 7 (10), 1081-1092, 2014 | 241 | 2014 |
| Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ... European heart journal 43 (7), e17-e25, 2022 | 213 | 2022 |
| Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta … D Giacoppo, F Alfonso, B Xu, BEPM Claessen, T Adriaenssens, C Jensen, ... European Heart Journal 41 (38), 3715-3728, 2020 | 203 | 2020 |
| Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome LP Hoebers, BE Claessen, J Elias, GD Dangas, R Mehran, ... International journal of cardiology 187, 90-96, 2015 | 202 | 2015 |
| Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI (Harmonizing … JW Suh, R Mehran, BE Claessen, K Xu, U Baber, G Dangas, H Parise, ... Journal of the American College of Cardiology 58 (17), 1750-1756, 2011 | 160 | 2011 |
| Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis D Giacoppo, F Alfonso, B Xu, BEPM Claessen, T Adriaenssens, C Jensen, ... Journal of the American College of Cardiology 75 (21), 2664-2678, 2020 | 157 | 2020 |
| Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous … GD Dangas, AS Kini, SK Sharma, JPS Henriques, BE Claessen, ... The American Journal of Cardiology 113 (2), 222-228, 2014 | 153 | 2014 |
| Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI … AJ Saltzman, GW Stone, BE Claessen, A Narula, S Leon-Reyes, G Weisz, ... JACC: Cardiovascular Interventions 4 (9), 1011-1019, 2011 | 152 | 2011 |
| Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary … BE Claessen, MA Beijk, V Legrand, W Ruzyllo, A Manari, O Varenne, ... Circulation: Cardiovascular Interventions 2 (4), 339-347, 2009 | 150 | 2009 |
| Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus-versus paclitaxel-eluting stents: pooled analysis from the … BE Claessen, PC Smits, DJ Kereiakes, H Parise, M Fahy, E Kedhi, ... JACC: Cardiovascular Interventions 4 (11), 1209-1215, 2011 | 144 | 2011 |
| Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary … RJ van der Schaaf, BE Claessen, MM Vis, LP Hoebers, KT Koch, ... The American journal of cardiology 105 (7), 955-959, 2010 | 140 | 2010 |